Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistribution. [electronic resource]
- Nanomedicine (London, England) Feb 2017
- 317-331 p. digital
Publication Type: Journal Article
1748-6963
10.2217/nnm-2016-0319 doi
Animals Antioxidants--administration & dosage Drug Delivery Systems--methods Hepatic Stellate Cells--metabolism Liver--metabolism Male Nanocapsules--chemistry Rats, Sprague-Dawley Receptors, Platelet-Derived Growth Factor--metabolism Retinol-Binding Proteins--metabolism Silybin Silymarin--administration & dosage Tissue Distribution